News
5d
Pharmaceutical Technology on MSNVertex wins European approval for Alyftrek, bolstering cystic fibrosis strongholdWith its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...
Take a straw and try to breathe through it. That's how Tayla Purves felt before she was placed on Trikafta. Ms Purves has cystic fibrosis, a genetic disease that primarily affects the lungs and ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
13d
AAP on MSN'Transformational': cystic fibrosis drug price slashedAffordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...
Keating and colleagues analyzed 398 patients (median age, 31 years; 59% male; 97% white) with cystic fibrosis aged at least 12 years who possessed the F508del-minimal function mutation in the ...
More Australians living with rarer types of cystic fibrosis will be able to access treatment for the first time when expanded ...
May 14—JAMESTOWN — For one Jamestown family, their first child was diagnosed with cystic fibrosis and each parent knew they were carriers of a mutated gene that causes the genetic disease. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results